DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹15,937 Cr | ₹14,863 Cr | ₹14,619 Cr | ₹11,387 Cr | ₹9,425 Cr |
What is the latest Total Liabilities ratio of DIVIS LABORATORIES ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹15,937 Cr |
Mar2023 | ₹14,863 Cr |
Mar2022 | ₹14,619 Cr |
Mar2021 | ₹11,387 Cr |
Mar2020 | ₹9,425 Cr |
How is Total Liabilities of DIVIS LABORATORIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹15,937 Cr | 7.23 | |
Mar2023 | ₹14,863 Cr | 1.67 | |
Mar2022 | ₹14,619 Cr | 28.39 | |
Mar2021 | ₹11,387 Cr | 20.82 | |
Mar2020 | ₹9,425 Cr | - |
Compare Total Liabilities of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹183,289.3 Cr | 1.4% | 4.1% | 50.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,284.0 Cr | -0% | -0.4% | 10.2% | Stock Analytics | |
CIPLA | ₹122,253.0 Cr | 0.5% | 1.6% | 1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,988.0 Cr | -1.2% | 7.1% | 18.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,921.0 Cr | 1.7% | 1.2% | 1.5% | Stock Analytics | |
MANKIND PHARMA | ₹100,677.0 Cr | 5% | 3.3% | 11% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 1.4% |
4.1% |
50.3% |
SENSEX | -0.7% |
3% |
5% |
You may also like the below Video Courses